Saturday 17 October 2026
Export BPTH’s income statement to Excel — free account
Bio-Path Holdings, Inc.
BPTH Healthcare Biotechnology
In the quarter to March 2026, EPS fell 101.2% and free cash flow grew 98.7%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
0.00
0.00
NaN
Follow BPTH
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| 157.01% | 0.00% | 256.49% | 419.87% |
+8 more TTM periods Free account |
|
| (605.50%) | 0.00% | (611.66%) | (420.09%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
102.61% | 0.00% | 139.38% | 171.67% | |
Free Cash Flow per Share |
(0.17) | — | (0.53) | (0.95) | |
Free Cash Flow |
(1.63) | — | (4.48) | (7.90) | |
| Other line items | |||||
Cash ROIC |
19.28% | 0.00% | 55.93% | 110.44% | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | — | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | — | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | — | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | 0.00% | |
Interest Coverage |
(44.04) | — | (65.76) | (435.40) | |
Operating CF/Net income |
0.19 | — | 0.40 | 0.64 | |
Depreciation/Fixed assets |
0.00 | — | 0.00 | 21.44 | |
Capex/Depreciation |
0.00 | — | 0.00 | 0.00 | |
Revenue per Share |
0.00 | — | 0.00 | 0.00 | |
Operating CF per Share |
(0.17) | — | (0.53) | (0.95) | |
Capex per Share |
0.00 | — | 0.00 | 0.00 |
Columns are period end dates